ATLASATLAS fair value
NT$152.06
Above fair value · 162% premium
Range: NT$127–NT$181Fair valuePrice
BORA PHARMACEUTICALS (6472.TW)
BORA PHARMACEUTICALS stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Taiwan Stock Exchange · Taiwan
NT$398.50▼ -1.12%
Prices as of Oct 27, 2026 · TWD
Chance of rising in 1 month
50%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on BORA PHARMACEUTICALS in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On BORA PHARMACEUTICALS
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates BORA PHARMACEUTICALS's fair value at about NT$152.06 per share (reasonable range: NT$126.69 to NT$180.68). At NT$398.50, the stock trades 162% above it.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives BORA PHARMACEUTICALS a 50% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between NT$370.72 and NT$427.30; in 9 out of 10, between NT$326.86 and NT$484.63. Estimated annual volatility is 41%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- NT$54.6B
- Market cap (USD)
- $1.7B
- P/E ratio
- 29.5
- Dividend yield
- 2.42%
- 52-week high
- NT$651.00
- 52-week low
- NT$330.50
- Revenue (12 months)
- NT$19.6B
- Gross margin
- 40.0%
- Operating margin
- 16.8%
- Net margin
- 7.9%
- Beta
- 0.44
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. BORA PHARMACEUTICALS sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks 6472.TW has traded between NT$330.50 and NT$651.00. Today it is 38.8% below that high and 21% above its low.
On the business: net margin is 7.9%; it trades at 29.5 times earnings.
Its beta is 0.44: it tends to move less than the market.
About the company
Bora Pharmaceuticals Co., LTD. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments.
Want to see everything about BORA PHARMACEUTICALS?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is BORA PHARMACEUTICALS (6472.TW) fair value?
About NT$152.06 per share according to ATLAS (reasonable range: NT$126.69 to NT$180.68). With the stock at NT$398.50, it is 162% above it.
What is the chance 6472.TW goes up next month?
50%: close to a coin flip. In half of the simulated outcomes, 6472.TW ends the month between NT$370.72 and NT$427.30.
How big is BORA PHARMACEUTICALS and what is its P/E ratio?
BORA PHARMACEUTICALS's market capitalization is NT$54.6B. Its price-to-earnings (P/E) ratio is 29.5: you pay NT$29.5 for each NT$1.00 of yearly earnings.
Does BORA PHARMACEUTICALS pay a dividend?
Yes. 6472.TW's current dividend yield is 2.42% at today's price (NT$398.50).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer